Donor testing services from LABS

LABS Inc., one of the premier transplant reference and consultative laboratories in the country, announced today that it will begin offering a full range of donor testing services to the transfusion medicine and blood services industry. LABS Inc.'s acquisition of Research and Diagnostic Laboratories in October brings its expertise to blood collection programs nationwide.

LABS Inc. has been serving the transplant community for nearly 30 years in the areas of infectious disease, immunogenetics and microbiology, bringing unparalleled consultative and regulatory expertise to its customers. LABS Inc.'s proven ability to manage partnerships and transport samples effectively and efficiently with timely result reporting will provide the blood services community with an alternative resource for all of their testing needs.

"LABS Inc. has earned a reputation as an industry leader in transplant medicine due to its quality of service and its expertise in donor eligibility testing, and we look forward to continuing this track record within the transfusion medicine and blood services community," said Elizabeth Hearty, Chief Executive Officer of LABS Inc. "Our depth and breadth of testing, combined with our flexibility, fast turn-around times and the ability to take on evolving services such as stem cell testing will make LABS Inc. the best resource for blood services customers across the country."

As a leading laboratory in transplant medicine, LABS Inc. runs a robust quality management system with regular internal and third party audits, a complaint management and error management system along with management review processes. This robust system has earned LABS Inc. an impeccable reputation for quality and safety in the industry that will now be enjoyed by the blood services community.

LABS Inc. has obtained all relevant licenses, certifications and accreditations to offer donor testing services. The Company will offer a complete testing menu to its blood services clients including infectious disease testing, red cell antibody screening with ID, microbiology screening for platelet products, HLA Class I and II antibody screening and leukocyte enumeration. The test results are all delivered through an electronic records system that can be exported to the client and interface seamlessly with client systems.